An Update on Aerosolized Antibiotics for Treating Hospital-Acquired and Ventilator-Associated Pneumonia in Adults
暂无分享,去创建一个
[1] J. Riera,et al. Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] J. Riera,et al. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] M. Kollef,et al. A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram‐Negative Ventilator‐Associated Pneumonia: IASIS Trial , 2017, Chest.
[4] C. Thomson,et al. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia. , 2016, Annals of the American Thoracic Society.
[5] J. Riera,et al. Intratracheal Administration of Antimicrobial Agents in Mechanically Ventilated Adults: An International Survey on Delivery Practices and Safety , 2016, Respiratory Care.
[6] Wen-Sen Lee,et al. Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[7] P. Korkmaz Ekren,et al. The Role of Aerolized Colistin in the Treatment of Hospital-Acquired Pneumonia: Experience of Multicenter From Turkey. , 2016, Critical care medicine.
[8] T. Demirdal,et al. Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? , 2016, Annals of Clinical Microbiology and Antimicrobials.
[9] J. Brożek,et al. Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] A. Torres,et al. Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis , 2015, Critical Care.
[11] A. Valachis,et al. The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia: A Systematic Review and Metaanalysis* , 2015, Critical care medicine.
[12] K. Kaye,et al. Colistin: Understanding and Applying Recent Pharmacokinetic Advances , 2015, Pharmacotherapy.
[13] M. Kollef,et al. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study , 2014, Critical Care.
[14] Matthieu Jacobs,et al. Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients , 2014, Antimicrobial Agents and Chemotherapy.
[15] T. Chao,et al. Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin , 2014, Biomedical journal.
[16] J. Chaudhuri,et al. Biological function of activation-induced cytidine deaminase (AID) , 2014, Biomedical journal.
[17] G. Smaldone,et al. Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit. , 2014, American journal of respiratory and critical care medicine.
[18] Young Keun Kim,et al. Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii , 2013, Yonsei medical journal.
[19] M. Antonelli,et al. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria. , 2013, Chest.
[20] Garrett E. Schramm,et al. Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study , 2013, BMC Anesthesiology.
[21] G. Iotti,et al. The importance of protecting the mechanical ventilator during colistin methanesulfonate nebulization , 2013, Intensive Care Medicine.
[22] Q. Lu,et al. Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii , 2012, Anesthesiology.
[23] Q. Lu,et al. Aerosolized Antibiotics for Ventilator-associated Pneumonia: Lessons from Experimental Studies , 2012, Anesthesiology.
[24] M. Kollef,et al. Use of Adjunctive Aerosolized Antimicrobial Therapy in the Treatment of Pseudomonas aeruginosa and Acinetobacter baumannii Ventilator-Associated Pneumonia , 2012, Respiratory Care.
[25] A. Tsakris,et al. Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients , 2012, Intensive Care Medicine.
[26] E. Alp,et al. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment? , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[27] G. Wood,et al. Aerosolised Antibacterials for the Prevention and Treatment of Hospital-Acquired Pneumonia , 2012, Drugs.
[28] M. Niederman,et al. BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia , 2012, Intensive Care Medicine.
[29] P. Jorens,et al. A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa , 2011, BMC infectious diseases.
[30] G. Wood. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia , 2011, Expert review of anti-infective therapy.
[31] H. Stass,et al. Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure. , 2011, Journal of aerosol medicine and pulmonary drug delivery.
[32] H. Stass,et al. Pharmacokinetics and tolerability of BAY41-6551 in subjects with chronic kidney disease. , 2011, Journal of aerosol medicine and pulmonary drug delivery.
[33] Q. Lu,et al. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. , 2011, American journal of respiratory and critical care medicine.
[34] M. Sánchez-Casado,et al. Utilización de la colistina nebulizada en la colonización e infección respiratoria por Acinetobacter baumannii en pacientes críticos , 2011 .
[35] M. Sánchez-Casado,et al. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients]. , 2011, Medicina intensiva.
[36] V. Thamlikitkul,et al. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. , 2010, The Journal of antimicrobial chemotherapy.
[37] M. Falagas,et al. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[38] Arzu Ari,et al. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. , 2010, Respiratory care.
[39] O. Atalay,et al. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. , 2010, Respiratory care.
[40] M. Klepser,et al. Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria , 2010, Pharmacotherapy.
[41] J. I. Kennedy,et al. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia , 2009, Critical care.
[42] R. McLeod,et al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials , 2008, Critical care medicine.
[43] G. Wood,et al. Aerosolized Antimicrobial Therapy in Acutely Ill Patients , 2000, Pharmacotherapy.